Related Experiment Videos
C-myc expression in exfoliated cells in serous effusions.
1Cytopathology Department, St Mary's Hospital, London.
Summary
Researchers investigated c-myc expression in benign and malignant effusions to improve cell discrimination. No significant differences were found, but the developed recombinant DNA technology can explore other oncogenes in cytological samples.
Area of Science:
- Oncology
- Molecular Biology
- Cytopathology
Background:
- Distinguishing benign from malignant cells in effusions is crucial for patient diagnosis.
- The c-myc oncogene is implicated in various cancers, making its expression a potential diagnostic marker.
Purpose of the Study:
- To assess c-myc expression in pleural and peritoneal fluids for improved discrimination between benign and malignant cells.
- To evaluate the utility of immunocytochemistry and recombinant DNA technology for oncogene detection in cytological samples.
Main Methods:
- Investigated 32 effusions for c-myc expression using immunocytochemical staining for protein detection.
- Employed Northern blotting, slot blotting, and in situ hybridization to detect c-myc mRNA via recombinant DNA technology.
Main Results:
- No significant difference in c-myc expression levels was observed between benign and malignant effusions.
- The study's findings regarding c-myc as a discriminator were inconclusive.
Conclusions:
- Current methods did not establish c-myc as a reliable marker for differentiating benign from malignant cells in effusions.
- The developed recombinant DNA techniques offer a valuable platform for future research into other oncogenes in cytological specimens.